A pill for our market access ills?

A pill for our market access ills?
New medicines should be made available to patients in Ireland at far more sustainable prices Pic: Bloomberg

New initiatives and generic brands have reduced medicine costs for the state, but more needs to be done to improve patients’ access to new treatments

According to Atul Gawande, professor in the department of health policy and management at Harvard School of Public Health, our ever-changing world of modern medicine challenges us with 13,000 diseases, 6,000 drugs and 4,000 surgical procedures. The rapidly evolving world of medicine plays a crucial part in helping us fight sickness and disease. That is why we, as a society, should pay close attention to the approach our government, and the HSE, is taking towards newly developed, high-tech medicines.

Please Subscribe or Log in to continue reading

Subscribe Login

Independent journalism every day

With digital access you can read The Business Post whenever, wherever, and however you want.

  • Unlimited access to all sections of The Business Post on desktop, tablet and mobile.
  • Breaking news, comment and analysis from the best Business Post writers seven days a week.
  • Live blogs of major news events.
  • Videos and podcasts from some of the industry's most respected journalists such as Michael Brennan, Susan Mitchell and Ian Guider.
  • Access to The Business Post's extensive archive​.

Related Articles

More from The Business Post